GET THE APP
Pharmacodynamics Innovations | Open Access Journals
Pharmaceutical Regulatory Affairs: Open Access

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Pharmacodynamics Innovations

Pharmacodynamics is that the study describes what a drug does to the body, involves receptor binding (including receptor sensitivity), post-receptor effects, and chemical interactions. Pharmacodynamics, with pharmacokinetics, helps explain the connection between the dose and response, i.e., the drug's effects. The pharmacologic response depends on the drug binding to its target. The concentration of the drug at the receptor site influences the drug's effect. A drug's pharmacodynamics are often suffering from physiologic changes thanks to disorders, aging, or other drugs. Disorders that affect pharmacodynamic responses include genetic mutations, thyrotoxicosis, malnutrition, myasthenia, Parkinson disease, and a few sorts of insulin-resistant DM . These disorders can change receptor binding, alter the extent of binding proteins, or decrease receptor sensitivity. Aging tends to affect pharmacodynamic responses through alterations in receptor binding or in post-receptor response sensitivity. Pharmacodynamic drug–drug interactions result in competition for receptor binding sites or alter the post-receptor response. Innovations are new ideas, device or process. Innovations are the appliance of higher solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through simpler products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks intoâ€Â the market or society.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Pharmaceutical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Citation image
Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport

View More »

 

Open Access Journals

arrow_upward arrow_upward